SCHEMBL17899550

SCHEMBL17899550

CCC1C/C(=C\c2ccc(Br)cc2)C(=O)/C(=C/c2ccc(Br)cc2)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
LMNA P02545 3/20 0.57
HTT P42858 3/20 0.57
RAB9A P51151 3/20 0.57
ALDH1A1 P00352 2/20 0.57
HSP90AA1 P07900 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
DRD3 P35462 1/20 0.57
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
POLB P06746 1/20 0.52
RECQL P46063 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
EGFR P00533 1/20 0.46
XDH P47989 1/20 0.46
ACHE P22303 5/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
BCHE P06276 4/20 0.43
PTGS2 P35354 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10977516 0.84 MAPT (0.57) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL18415114 0.84 MAPT (0.57) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10977512 0.84 MAPT (0.57) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL17899528 0.81 MAPT (0.65) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10974381 0.81 CYP1A2 (0.60) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10974383 0.81 CYP1A2 (0.60) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10979150 0.80 ALDH1A1 (0.53) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10979146 0.80 ALDH1A1 (0.53) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10977686 0.78 MAPT (0.51) MAPTLMNAHTTRAB9AALDH1A1
SCHEMBL10979490 0.78 MAPT (0.51) MAPTLMNAHTTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS BAYLOR COLLEGE OF MEDICINE (US) 2023-11-09 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents BAYLOR COLLEGE OF MEDICINE (US) 2023-07-25 US disclosed
WO-2016109470-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR PROTEINS AND THEIR USE IN THE TREATMENT OF CANCER BAYLOR COLLEGE OF MEDICINE (US) 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708350-B2 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents NCOA3, FABP3, NCOA1 MAPT 4809/4885LMNA 2223/4885HTT 4521/4885
US-20230357200-A1 SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS NCOA3, FABP3, NCOA1 MAPT 4809/4885LMNA 2223/4885HTT 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.